TB Alliance

TB Alliance launches combination drug trial, establishes new pathway to TB and MDR-TB treatment

Goal is to find new treatment that takes months, not years, and cures multiple forms of tuberculosis.

Read More →

TB Alliance launches toolkit to support TB R&D advocacy

The TB Alliance and other organizations spearheading the research and development of new and improved tools to treat, diagnose, and prevent TB need your help to ensure that appropriate levels of political commitment and financial investment are dedicated toward TB R&D.

Read More →

TB Alliance and partners awarded grant from NIAID to speed TB R&D

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a grant to the TB Alliance as a member of the Consortium for TB Biomarkers (CTB2) project. The award, distributed over five years, will support the search for tuberculosis (TB) biomarkers, which are biological indicators that can measure the progress of disease or the effects of treatment, and are critical to markedly shortening the time to develop urgently needed new TB regimens.

Read More →

Page 6 of 6 · Total posts: 3

←First 5 6